208 related articles for article (PubMed ID: 34747529)
1. Cyanobacteria derived compounds: Emerging drugs for cancer management.
Shahid A; Khurshid M; Aslam B; Muzammil S; Mehwish HM; Rajoka MSR; Hayat HF; Sarfraz MH; Razzaq MK; Nisar MA; Waseem M
J Basic Microbiol; 2022 Sep; 62(9):1125-1142. PubMed ID: 34747529
[TBL] [Abstract][Full Text] [Related]
2. Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis.
Costa M; Costa-Rodrigues J; Fernandes MH; Barros P; Vasconcelos V; Martins R
Mar Drugs; 2012 Oct; 10(10):2181-2207. PubMed ID: 23170077
[TBL] [Abstract][Full Text] [Related]
3. Cyanobacteria as Natural Therapeutics and Pharmaceutical Potential: Role in Antitumor Activity and as Nanovectors.
Qamar H; Hussain K; Soni A; Khan A; Hussain T; Chénais B
Molecules; 2021 Jan; 26(1):. PubMed ID: 33466486
[TBL] [Abstract][Full Text] [Related]
4. Anticancer Compounds from Cyanobacteria and their Implications in Apoptosis.
Gupta A; Singh PR; Singh AP; Kumari N; Jaiswal J; Sahu N; Mishra S; Pathak J; Sinha RP
Curr Protein Pept Sci; 2023; 24(10):805-819. PubMed ID: 37055887
[TBL] [Abstract][Full Text] [Related]
5. New Drugs from the Sea: Pro-Apoptotic Activity of Sponges and Algae Derived Compounds.
Ercolano G; De Cicco P; Ianaro A
Mar Drugs; 2019 Jan; 17(1):. PubMed ID: 30621025
[TBL] [Abstract][Full Text] [Related]
6. Marine Cyanobacteria and Microalgae Metabolites-A Rich Source of Potential Anticancer Drugs.
Mondal A; Bose S; Banerjee S; Patra JK; Malik J; Mandal SK; Kilpatrick KL; Das G; Kerry RG; Fimognari C; Bishayee A
Mar Drugs; 2020 Sep; 18(9):. PubMed ID: 32961827
[TBL] [Abstract][Full Text] [Related]
7. A review of pharmacological and toxicological potentials of marine cyanobacterial metabolites.
Nagarajan M; Maruthanayagam V; Sundararaman M
J Appl Toxicol; 2012 Mar; 32(3):153-85. PubMed ID: 21910132
[TBL] [Abstract][Full Text] [Related]
8. Marine Cyanobacteria as Sources of Lead Anticancer Compounds: A Review of Families of Metabolites with Cytotoxic, Antiproliferative, and Antineoplastic Effects.
Robles-Bañuelos B; Durán-Riveroll LM; Rangel-López E; Pérez-López HI; González-Maya L
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956762
[TBL] [Abstract][Full Text] [Related]
9. Cyanobacteria as a Source for Novel Anti-Leukemic Compounds.
Humisto A; Herfindal L; Jokela J; Karkman A; Bjørnstad R; Choudhury RR; Sivonen K
Curr Pharm Biotechnol; 2016; 17(1):78-91. PubMed ID: 26306745
[TBL] [Abstract][Full Text] [Related]
10. Bioactive substances of cyanobacteria and microalgae: Sources, metabolism, and anticancer mechanism insights.
Bouyahya A; Bakrim S; Chamkhi I; Taha D; El Omari N; El Mneyiy N; El Hachlafi N; El-Shazly M; Khalid A; Abdalla AN; Goh KW; Ming LC; Goh BH; Aanniz T
Biomed Pharmacother; 2024 Jan; 170():115989. PubMed ID: 38103309
[TBL] [Abstract][Full Text] [Related]
11. Developments of Cyanobacteria for Nano-Marine Drugs: Relevance of Nanoformulations in Cancer Therapies.
Bajpai VK; Shukla S; Kang SM; Hwang SK; Song X; Huh YS; Han YK
Mar Drugs; 2018 May; 16(6):. PubMed ID: 29882898
[TBL] [Abstract][Full Text] [Related]
12. Caspase-driven cancer therapies: Navigating the bridge between lab discoveries and clinical applications.
Allani M; Akhilesh ; Tiwari V
Cell Biochem Funct; 2024 Mar; 42(2):e3944. PubMed ID: 38348642
[TBL] [Abstract][Full Text] [Related]
13. Bioactive natural products from marine cyanobacteria for drug discovery.
Tan LT
Phytochemistry; 2007 Apr; 68(7):954-79. PubMed ID: 17336349
[TBL] [Abstract][Full Text] [Related]
14. Exploring marine cyanobacteria for lead compounds of pharmaceutical importance.
Uzair B; Tabassum S; Rasheed M; Rehman SF
ScientificWorldJournal; 2012; 2012():179782. PubMed ID: 22545008
[TBL] [Abstract][Full Text] [Related]
15. Structural Diversity, Biological Properties and Applications of Natural Products from Cyanobacteria. A Review.
Shah SAA; Akhter N; Auckloo BN; Khan I; Lu Y; Wang K; Wu B; Guo YW
Mar Drugs; 2017 Nov; 15(11):. PubMed ID: 29125580
[TBL] [Abstract][Full Text] [Related]
16. Tiny Microbes with a Big Impact: The Role of Cyanobacteria and Their Metabolites in Shaping Our Future.
Mazard S; Penesyan A; Ostrowski M; Paulsen IT; Egan S
Mar Drugs; 2016 May; 14(5):. PubMed ID: 27196915
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of cancer cells' proliferation by compounds included in extracts from Baltic Sea cyanobacteria.
Felczykowska A; Pawlik A; Mazur-Marzec H; Toruńska-Sitarz A; Narajczyk M; Richert M; Węgrzyn G; Herman-Antosiewicz A
Toxicon; 2015 Dec; 108():1-10. PubMed ID: 26410109
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Application of Diverse Marine-derived Natural Products in Cancer Therapy.
Yun CW; Kim HJ; Lee SH
Anticancer Res; 2019 Oct; 39(10):5261-5284. PubMed ID: 31570422
[TBL] [Abstract][Full Text] [Related]
19. Marine benthic cyanobacteria contain apoptosis-inducing activity synergizing with daunorubicin to kill leukemia cells, but not cardiomyocytes.
Oftedal L; Selheim F; Wahlsten M; Sivonen K; Døskeland SO; Herfindal L
Mar Drugs; 2010 Oct; 8(10):2659-72. PubMed ID: 21116413
[TBL] [Abstract][Full Text] [Related]
20. Bioactive compounds from marine invertebrates as potent anticancer drugs: the possible pharmacophores modulating cell death pathways.
Patra S; Praharaj PP; Panigrahi DP; Panda B; Bhol CS; Mahapatra KK; Mishra SR; Behera BP; Jena M; Sethi G; Patil S; Patra SK; Bhutia SK
Mol Biol Rep; 2020 Sep; 47(9):7209-7228. PubMed ID: 32797349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
